Trial results for new lung cancer drug are 'off the charts', say doctors - The Guardian
5/31/2024
Trial results for new lung cancer drug are 'off the charts', say doctors The GuardianLung cancer treatment: Pfizer's Lorbrena extends life in some non-small cell lung cancers NBC NewsPfizer's drug for advanced lung cancer shows promising long-term trial results CNBCFor one rare type of lung cancer, Pfizer pill reduces progression by 81% STATPfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data Reuters...
Original
Tags: billion | cancer | doctors | drug | guardian | life | rare | results | sales | sees | shows | treatment | trial | type